Resistance to glucose starvation as metabolic trait of platinumresistant human epithelial ovarian cancer cells

Anna Pastò, Anna Pagotto, Giorgia Pilotto, Angela De Paoli, Gian Luca De Salvo, Alessandra Baldoni, Maria Ornella Nicoletto, Francesca Ricci, Giovanna Damia, Chiara Bellio, Stefano Indraccolo, Alberto Amadori

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Deregulated glucose metabolism is observed in cancer but whether this metabolic trait influences response to or is modulated by cytotoxic drugs is unknown. We show here that tumor cells from epithelial ovarian cancer (EOC) patients can be categorized, according to their in vitro viability under glucose starvation, into glucose deprivation-sensitive (glucose-addicted, GA) and glucose deprivation-resistant (glucose non-addicted, GNA). When EOC cells were cultured in the absence of glucose, all samples from platinum (PLT)-sensitive patients felt into the GA group; they disclosed higher expression of glucose metabolism enzymes, higher proliferation rates and in vitro sensitivity to PLT. Moreover, GA patients showed reduced multi-drug resistance pump expression and autophagy, compared to GNA samples. The close association between PLT sensitivity and glucose metabolic profile was confirmed in a xenograft model, where a stringent parallelism between PLT sensitivity/resistance and glucose metabolism was identified. Finally, in a cohort of naïve EOC patients categorized as GA or GNA at diagnosis, Kaplan Meier curves showed that the GA phenotype was associated with significantly better progression-free survival, compared to GNA patients.

Original languageEnglish
Pages (from-to)6433-6445
Number of pages13
JournalOncotarget
Volume8
Issue number4
DOIs
Publication statusPublished - 2017

Fingerprint

Starvation
Glucose
Platinum
Ovarian epithelial cancer
Metabolome
Autophagy
Multiple Drug Resistance
Heterografts
Disease-Free Survival

Keywords

  • Autophagy
  • Glucose addiction
  • Metabolism
  • Ovarian cancer
  • Platinum resistance

ASJC Scopus subject areas

  • Oncology

Cite this

Resistance to glucose starvation as metabolic trait of platinumresistant human epithelial ovarian cancer cells. / Pastò, Anna; Pagotto, Anna; Pilotto, Giorgia; Paoli, Angela De; De Salvo, Gian Luca; Baldoni, Alessandra; Nicoletto, Maria Ornella; Ricci, Francesca; Damia, Giovanna; Bellio, Chiara; Indraccolo, Stefano; Amadori, Alberto.

In: Oncotarget, Vol. 8, No. 4, 2017, p. 6433-6445.

Research output: Contribution to journalArticle

@article{f92bb05725094f0e995f1e1353031f31,
title = "Resistance to glucose starvation as metabolic trait of platinumresistant human epithelial ovarian cancer cells",
abstract = "Deregulated glucose metabolism is observed in cancer but whether this metabolic trait influences response to or is modulated by cytotoxic drugs is unknown. We show here that tumor cells from epithelial ovarian cancer (EOC) patients can be categorized, according to their in vitro viability under glucose starvation, into glucose deprivation-sensitive (glucose-addicted, GA) and glucose deprivation-resistant (glucose non-addicted, GNA). When EOC cells were cultured in the absence of glucose, all samples from platinum (PLT)-sensitive patients felt into the GA group; they disclosed higher expression of glucose metabolism enzymes, higher proliferation rates and in vitro sensitivity to PLT. Moreover, GA patients showed reduced multi-drug resistance pump expression and autophagy, compared to GNA samples. The close association between PLT sensitivity and glucose metabolic profile was confirmed in a xenograft model, where a stringent parallelism between PLT sensitivity/resistance and glucose metabolism was identified. Finally, in a cohort of na{\"i}ve EOC patients categorized as GA or GNA at diagnosis, Kaplan Meier curves showed that the GA phenotype was associated with significantly better progression-free survival, compared to GNA patients.",
keywords = "Autophagy, Glucose addiction, Metabolism, Ovarian cancer, Platinum resistance",
author = "Anna Past{\`o} and Anna Pagotto and Giorgia Pilotto and Paoli, {Angela De} and {De Salvo}, {Gian Luca} and Alessandra Baldoni and Nicoletto, {Maria Ornella} and Francesca Ricci and Giovanna Damia and Chiara Bellio and Stefano Indraccolo and Alberto Amadori",
year = "2017",
doi = "10.18632/oncotarget.14118",
language = "English",
volume = "8",
pages = "6433--6445",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "4",

}

TY - JOUR

T1 - Resistance to glucose starvation as metabolic trait of platinumresistant human epithelial ovarian cancer cells

AU - Pastò, Anna

AU - Pagotto, Anna

AU - Pilotto, Giorgia

AU - Paoli, Angela De

AU - De Salvo, Gian Luca

AU - Baldoni, Alessandra

AU - Nicoletto, Maria Ornella

AU - Ricci, Francesca

AU - Damia, Giovanna

AU - Bellio, Chiara

AU - Indraccolo, Stefano

AU - Amadori, Alberto

PY - 2017

Y1 - 2017

N2 - Deregulated glucose metabolism is observed in cancer but whether this metabolic trait influences response to or is modulated by cytotoxic drugs is unknown. We show here that tumor cells from epithelial ovarian cancer (EOC) patients can be categorized, according to their in vitro viability under glucose starvation, into glucose deprivation-sensitive (glucose-addicted, GA) and glucose deprivation-resistant (glucose non-addicted, GNA). When EOC cells were cultured in the absence of glucose, all samples from platinum (PLT)-sensitive patients felt into the GA group; they disclosed higher expression of glucose metabolism enzymes, higher proliferation rates and in vitro sensitivity to PLT. Moreover, GA patients showed reduced multi-drug resistance pump expression and autophagy, compared to GNA samples. The close association between PLT sensitivity and glucose metabolic profile was confirmed in a xenograft model, where a stringent parallelism between PLT sensitivity/resistance and glucose metabolism was identified. Finally, in a cohort of naïve EOC patients categorized as GA or GNA at diagnosis, Kaplan Meier curves showed that the GA phenotype was associated with significantly better progression-free survival, compared to GNA patients.

AB - Deregulated glucose metabolism is observed in cancer but whether this metabolic trait influences response to or is modulated by cytotoxic drugs is unknown. We show here that tumor cells from epithelial ovarian cancer (EOC) patients can be categorized, according to their in vitro viability under glucose starvation, into glucose deprivation-sensitive (glucose-addicted, GA) and glucose deprivation-resistant (glucose non-addicted, GNA). When EOC cells were cultured in the absence of glucose, all samples from platinum (PLT)-sensitive patients felt into the GA group; they disclosed higher expression of glucose metabolism enzymes, higher proliferation rates and in vitro sensitivity to PLT. Moreover, GA patients showed reduced multi-drug resistance pump expression and autophagy, compared to GNA samples. The close association between PLT sensitivity and glucose metabolic profile was confirmed in a xenograft model, where a stringent parallelism between PLT sensitivity/resistance and glucose metabolism was identified. Finally, in a cohort of naïve EOC patients categorized as GA or GNA at diagnosis, Kaplan Meier curves showed that the GA phenotype was associated with significantly better progression-free survival, compared to GNA patients.

KW - Autophagy

KW - Glucose addiction

KW - Metabolism

KW - Ovarian cancer

KW - Platinum resistance

UR - http://www.scopus.com/inward/record.url?scp=85010748373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010748373&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14118

DO - 10.18632/oncotarget.14118

M3 - Article

VL - 8

SP - 6433

EP - 6445

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 4

ER -